Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Neoplasms 3Pancreatic Neoplasms 2Neoplasm Metastasis 2Lymphoma, Follicular 2Lung Neoplasms 2Colonic Neoplasms 2Breast Neoplasms 2Thyroid Neoplasms 1Stomach Neoplasms 1Rectal Neoplasms 1Prostatic Neoplasms 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Multiple Pulmonary Nodules 1Multiple Myeloma 1Mouth Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell, Marginal Zone 1Liver Metastases 1Liver Malignancy 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hematologic Neoplasms 1Disease 1Colorectal Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Lobular 1Brain Neoplasms 1Bile Duct Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 4Surgical Procedures, Operative 3Iodine-131 3Iodine-124 3Biopsy 3selpercatinib 2lenvatinib 2Watchful Waiting 2Thyrotropin Alfa 2Therapeutics 2Nivolumab 2Fluorodeoxyglucose F18 2Cyclophosphamide 2Cetuximab 2Biopsy, Fine-Needle 2trastuzumab deruxtecan 1trametinib 1sintilimab 1sacituzumab govitecan 1repotrectinib 1pralsetinib 1pembrolizumab 1gallium Ga 68 dotatate 1fludarabine phosphate 1defactinib 1dabrafenib 1cemiplimab 1brodalumab 1binimetinib 1anlotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Thyroid Neoplasms × Positron Emission Tomography Computed Tomography × Clear all
NCT03647358 2026-04-14

Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
60 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡